Article Versions Notes

Hidalgo-Gajardo A, Gutiérrez N, Lamazares E, Espinoza F, Escobar-Riquelme F, Leiva MJ, Villavicencio C, Mena-Ulecia K, Montesino R, Altamirano C, et al. Co-Formulation of Recombinant Porcine IL-18 Enhances the Onset of Immune Response in a New Lawsonia intracellularis Vaccine. Vaccines. 2023; 11(12):1788. https://doi.org/10.3390/vaccines11121788

Hidalgo-Gajardo, Angela, Nicolás Gutiérrez, Emilio Lamazares, Felipe Espinoza, Fernanda Escobar-Riquelme, María J. Leiva, Carla Villavicencio, Karel Mena-Ulecia, Raquel Montesino, Claudia Altamirano, and et al. 2023. "Co-Formulation of Recombinant Porcine IL-18 Enhances the Onset of Immune Response in a New Lawsonia intracellularis Vaccine" Vaccines 11, no. 12: 1788. https://doi.org/10.3390/vaccines11121788

Hidalgo-Gajardo, A., Gutiérrez, N., Lamazares, E., Espinoza, F., Escobar-Riquelme, F., Leiva, M. J., Villavicencio, C., Mena-Ulecia, K., Montesino, R., Altamirano, C., Sánchez, O., Rivas, C. I., Ruíz, Á., & Toledo, J. R. (2023). Co-Formulation of Recombinant Porcine IL-18 Enhances the Onset of Immune Response in a New Lawsonia intracellularis Vaccine. Vaccines, 11(12), 1788. https://doi.org/10.3390/vaccines11121788